All Stories

  1. Improvements in throat function and qualities of sore throat from locally applied flurbiprofen 8.75 mg in spray or lozenge format: findings from a randomized trial of patients with upper respiratory tract infection in the Russian Federation

    Article • Journal of Pain Research, June 2018, Dove Medical Press

    Natalia Burova

  2. Efficacy of flurbiprofen 8.75 mg delivered as a spray or lozenge in patients with sore throat due to upper respiratory tract infection: a randomized, non-inferiority trial in the Russian Federation

    Article • Journal of Pain Research, July 2017, Dove Medical Press

    Natalia Burova